Biocon Ltd has successfully priced the debut issuance of senior secured Notes worth USD 800 million (~₹66,763 million) for its subsidiary, Biocon Biologics. These bonds, which have a coupon rate of 6.67%, will mature in 2029 and are expected to be listed on the Singapore Stock Exchange. The transaction, scheduled for settlement on October 9, …